STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 68 filers reported holding STOKE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,741,147 | -13.7% | 188,640 | +20.0% | 0.37% | +33.6% |
Q3 2022 | $2,018,000 | -74.3% | 157,200 | -32.6% | 0.28% | -47.3% |
Q2 2021 | $7,847,000 | +34.0% | 233,135 | +54.7% | 0.53% | +18.3% |
Q1 2021 | $5,854,000 | +838.1% | 150,729 | +453.1% | 0.45% | +475.6% |
Q1 2020 | $624,000 | -91.4% | 27,254 | -89.4% | 0.08% | -87.0% |
Q4 2019 | $7,261,000 | -1.7% | 256,380 | -26.0% | 0.60% | -47.6% |
Q3 2019 | $7,384,000 | -24.0% | 346,380 | -1.3% | 1.14% | -14.1% |
Q2 2019 | $9,718,000 | – | 350,944 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |